Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL
8d agoen
From the article
Conditions : ALL (Acute B-Lymphoblastic Leukemia) Interventions : Drug: Blinatumomab Injection; Other: Donor Lymphocyte Infusion (DLI) Sponsors : Liping Dou Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus
This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce
lupus.bmj.com·26d agoThe Evolving Role of Targeted Therapies in Chronic Lymphocytic Leukemia Care
ltcnews.com·13d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.